Russia's sovereign wealth fund has filed for registration of Sputnik V in the European Union and expects it to be reviewed in February, the official account promoting the COVID-19 vaccine tweeted on Wednesday.
The Sputnik V and European Medical Agency (EMA) teams held a scientific review of the vaccine on Tuesday, the Sputnik V account said, adding the EMA will take a decision on the authorization of the vaccine based on the reviews. (https://bit.ly/39OQZDR)
The vaccine has already been approved in Argentina, Belarus, Serbia and other countries.
Saif al-Islam Gaddafi, son of late Libyan leader, shot dead
Sudanese army says it's broken siege of famine-stricken Kadugli
WHO says first five patients evacuated via Gaza's Rafah crossing
Russia pounds Ukraine with record number of missiles, Zelenskyy says
